Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2019

Dec 4, 2019

32845_dirs_2019-12-04_bd6acab8-9561-426a-a587-17fd50c68af7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-12-02

Reporting Person: Maharaj Gary R (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-12-02 Common Stock S 4270 $40.3303 Disposed 144317 Direct
2019-12-02 Common Stock S 730 $40.7437 Disposed 143587 Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.

F2: Reflects the weighted average price of 4,270 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2019 with sale prices ranging from $39.725 to $40.67 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reflects the weighted average price of 730 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2019 with sale prices ranging from $40.725 to $40.88 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.